Piper Sandler Cuts Teladoc Health (NYSE:TDOC) Price Target to $12.00

Teladoc Health (NYSE:TDOC) had its target price decreased by Piper Sandler from $13.00 to $12.00 in a report issued on Thursday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the health services provider’s stock.

Several other equities research analysts have also issued reports on the company. Bank of America lifted their price objective on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft raised their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada raised their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday. Finally, The Goldman Sachs Group raised their price target on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, February 18th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $11.44.

Teladoc Health Price Performance

NYSE:TDOC opened at $9.56 on Thursday. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of -1.66 and a beta of 1.05. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $15.95. The stock has a fifty day moving average of $10.62 and a 200 day moving average of $9.57. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, research analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Brucke Financial Inc. purchased a new position in Teladoc Health during the 4th quarter valued at about $92,000. Vise Technologies Inc. increased its holdings in Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the period. PharVision Advisers LLC purchased a new position in Teladoc Health during the 4th quarter valued at about $301,000. Twinbeech Capital LP increased its holdings in Teladoc Health by 63.8% during the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock valued at $3,479,000 after purchasing an additional 149,118 shares during the period. Finally, Two Sigma Advisers LP increased its holdings in Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.